Patient-centred healthcare is here to stay, so how can pharma sales embrace it?
Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland tells us what the company looks for in a good app and how digital health can change the industry
Feat.: Making health apps a reality; Brexit and the supply chain; Patiet-centric sales
Why medical affairs is the most important role in the future of pharma
The myriad ways digital tools could change everything for pharma and the NHS
The Scottish Medicines Consortium has approved funding for four newly licensed medicines, expanding NHS treatments options in Scotland for ovarian cancer, lung cancer, urea cycle disorders and acute hereditary angioedema.
14th August 2018
Roche/Novartis’ Xolair has been awarded breakthrough status in the US for treatment of severe allergic reactions after accidental exposure to foods allergens.
14th August 2018
The National Institute for Health and Care Excellence is not recommending NHS use of Biogen’s Spinraza for the rare genetic disorder spinal muscular atrophy (SMA) at this time.
14th August 2018
US regulators have accepted for review a targeted, Gram-positive investigational antibiotic developed by UK biopharma Motif Bio for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
14th August 2018
UK-American biotech Orchard Therapeutics has raised $150 million to fuel development of its gene therapy pipeline.
14th August 2018
CRISPR could help turn Alzhimer's findings into a cure, but there are several barriers to overcome first
An overview of the latest drug developments in this notoriously-difficult disease area
The potential for oral delivery could completely change the landscape for biologics
Unclear ambitions and disjointed initiatives are threatening pharmaceutical companies’ ROI from advanced technologies
Katie Ruane was just 22 when diagnosed with CML, and while drugs keep the disease in remission it still takes a huge toll on her life
NHS England’s assurance process provides a window of opportunity for pharma – but communication and joint working with the health service is key
The failure of several Alzheimer’s drug trials in the past year has dampened, but not destroyed, hopes for a cure
Home DNA tests are now common, but using genome sequencing to personalise drugs still has some way to go
The regulatory impacts of Brexit could be far-reaching, so now is not the time to take a ‘wait and see’ approach
The myriad ways digital tools could change everything for pharma and the NHS
Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland tells us what the company looks for in a good app and how digital health can change the industry
Patient-centred healthcare is here to stay, so how can pharma sales embrace it?
Why patient centricity throughout the lifecycle is not a fad, sales tactic or trend
Simon Grime, director of Fendix, explains how pharma can utilise its wealth of existing resources and content to improve collaboration with the NHS online
Peter Cherry, PhD, Medmeme’s vice president, information systems, explores how pharma can identify predatory journals and conferences
The importance of a patient-centric focus to improve the real-world use of medicine was extensively discussed during the 3rd Annual Patient Engagement and Experience Conference (16–17th May 2018, Amsterdam, Netherlands).
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
